TCT 288: Implantation Depth and Need for Permanent Pacemaker Implantation after Transcatheter Aortic Valve Replacement with the JenaValve System in Patients with Severe Aortic Regurgitation
Presenter:
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Abbott; JenaValve; Medtronic